| KMDVX | VMVAX | KMDVX / VMVAX | |
| Total Expense Ratio | 1.20 | 0.07 | 1,714% |
| Annual Report Gross Expense Ratio | 1.41 | 0.07 | 2,014% |
| Fund Existence | 14 years | 14 years | - |
| Gain YTD | 10.893 | 10.975 | 99% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 126M | 32.6B | 0% |
| Annual Yield % from dividends | 0.99 | 2.14 | 46% |
| Returns for 1 year | 3.00 | 9.73 | 31% |
| Returns for 3 years | 26.08 | 33.24 | 78% |
| Returns for 5 years | 49.38 | 53.90 | 92% |
| Returns for 10 years | 117.53 | 110.28 | 107% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HIGUX | 22.85 | 0.11 | +0.48% |
| Carillon Eagle Growth & Income R6 | |||
| IJPTX | 12.95 | 0.04 | +0.31% |
| VY® JPMorgan Emerging Markets Equity S2 | |||
| USLCX | 30.55 | 0.07 | +0.23% |
| JHancock U.S. Global Leaders Growth C | |||
| RPBAX | 28.55 | 0.05 | +0.18% |
| T. Rowe Price Balanced | |||
| PUMYX | 15.04 | N/A | N/A |
| PACE Small/Medium Co Growth Equity Y | |||